Travere Therapeutics Inc (TVTX) — Working Capital to Net Assets Ratio
Travere Therapeutics Inc (TVTX) has a Working Capital to Net Assets ratio of 270.7% as of March 2026. Working capital of $267.24 Million (current assets of $392.68 Million minus current liabilities of $125.44 Million) is measured against net assets of $98.73 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Travere Therapeutics Inc balance sheet independence to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Travere Therapeutics Inc Working Capital to Net Assets (2010–2025)
This chart shows how Travere Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 16 annual periods from 2010 to 2025. As of March 2026, the ratio stands at 270.7%, reflecting working capital of $267.24 Million against net assets of $98.73 Million USD. Check Travere Therapeutics Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Travere Therapeutics Inc (2010–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Travere Therapeutics Inc from 2010 to 2025, covering 16 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Travere Therapeutics Inc market cap and net worth.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 241.8% | $277.66 Million | $114.83 Million | $437.56 Million | $159.90 Million | ▼ -123.7 pp |
| 2024 | 365.5% | $215.95 Million | $59.08 Million | $416.70 Million | $200.75 Million | ▲ +147.0 pp |
| 2023 | 218.5% | $438.87 Million | $200.81 Million | $616.77 Million | $177.91 Million | ▼ -584.9 pp |
| 2022 | 803.4% | $344.27 Million | $42.85 Million | $486.44 Million | $142.16 Million | ▲ +651.6 pp |
| 2021 | 151.8% | $458.74 Million | $302.11 Million | $582.83 Million | $124.09 Million | ▲ +1.4 pp |
| 2020 | 150.4% | $317.75 Million | $211.21 Million | $410.41 Million | $92.66 Million | ▼ -0.4 pp |
| 2019 | 150.8% | $333.62 Million | $221.20 Million | $429.06 Million | $95.45 Million | ▲ +27.9 pp |
| 2018 | 122.9% | $391.06 Million | $318.25 Million | $495.68 Million | $104.62 Million | ▲ +41.0 pp |
| 2017 | 81.9% | $240.14 Million | $293.13 Million | $325.81 Million | $85.67 Million | ▲ +1.0 pp |
| 2016 | 80.9% | $249.09 Million | $307.77 Million | $332.35 Million | $83.26 Million | ▲ +8.9 pp |
| 2015 | 72.1% | $216.13 Million | $299.97 Million | $301.93 Million | $85.80 Million | ▼ -116.4 pp |
| 2014 | 188.5% | $-70.20 Million | $-37.25 Million | $37.33 Million | $107.54 Million | ▲ +37.2 pp |
| 2013 | 151.3% | $-27.71 Million | $-18.31 Million | $7.50 Million | $35.21 Million | ▼ -17.9 pp |
| 2012 | 169.2% | $-5.77 Million | $-3.41 Million | $33.22K | $5.80 Million | ▲ +69.2 pp |
| 2011 | 100.0% | $-63.08K | $-63.08K | $3.91K | $66.99K | ▲ +0.0 pp |
| 2010 | 100.0% | $-60.26K | $-60.26K | $3.96K | $64.21K | — |